[
  {
    "date": "2023-12-30",
    "symbol": "SPRO",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "security12btitle": "Common Stock, $0.001 par value per share",
    "tradingsymbol": "SPRO",
    "securityexchangename": "NASDAQ",
    "entityregistrantname": "SPERO THERAPEUTICS, INC.",
    "entitycentralindexkey": 1701108,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityshellcompany": "false",
    "entityfilenumber": "001-38266",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "46-4590683",
    "entityaddressaddressline1": "675 Massachusetts Avenue,",
    "entityaddressaddressline2": "14th Floor",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2139,
    "cityareacode": 857,
    "localphonenumber": "242-1600",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "false",
    "auditorname": "PricewaterhouseCoopers LLP",
    "auditorlocation": "Boston, Massachusetts",
    "documentfinstmterrorcorrectionflag": "false",
    "auditorfirmid": 238,
    "cashandcashequivalentsatcarryingvalue": 76333000,
    "collaborationreceivablerelatedpartiescurrent": 49152000,
    "otherreceivables": 1545000,
    "prepaidexpenseandotherassetscurrent": 4178000,
    "assetscurrent": 131208000,
    "propertyplantandequipmentnet": 2000,
    "collaborationreceivablerelatedpartiesnoncurrent": 46590000,
    "operatingleaserightofuseasset": 4155000,
    "otherassetsnoncurrent": 435000,
    "assets": 182390000,
    "accountspayablecurrent": 1378000,
    "accruedexpensesandothercurrentliabilities": 6557000,
    "operatingleaseliabilitycurrent": 1718000,
    "taxespayablecurrent": 387000,
    "deferredrevenuecurrent": 2132000,
    "deferredrevenuecurrentrelatedparty": 24981000,
    "liabilitiescurrent": 37153000,
    "operatingleaseliabilitynoncurrent": 3825000,
    "deferredrevenuenoncurrent": 10825000,
    "deferredrevenuenoncurrentrelatedpartys": 23606000,
    "otherlongtermdebtnoncurrent": 87000,
    "liabilities": 75496000,
    "commonstockvalue": 53000,
    "additionalpaidincapitalcommonstock": 497913000,
    "retainedearningsaccumulateddeficit": -391072000,
    "stockholdersequity": 106894000,
    "liabilitiesandstockholdersequity": 182390000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 120000000,
    "commonstocksharesissued": 52999680,
    "commonstocksharesoutstanding": 52999680,
    "grantrevenue": 7046000,
    "collaborationrevenuerelatedparty": 95802000,
    "revenuefromcontractwithcustomerexcludingassessedtax": 933000,
    "typeofrevenueextensiblelist": "http://fasb.org/us-gaap/2023#LicenseMember",
    "revenues": 103781000,
    "researchanddevelopmentexpense": 51440000,
    "generalandadministrativeexpense": 25554000,
    "assetimpairmentcharges": 5306000,
    "operatingexpenses": 82300000,
    "operatingincomeloss": 21481000,
    "investmentincomeinterest": 3937000,
    "othernonoperatingincomeexpense": -14000,
    "nonoperatingincomeexpense": 3923000,
    "incomelossfromcontinuingoperationsbeforeinterestexpenseinterestincomeincometaxesextraordinaryitemsnoncontrollinginterestsnet": 25404000,
    "incometaxexpensebenefit": 2598000,
    "profitloss": 22806000,
    "earningspersharebasic": 0.43,
    "earningspersharediluted": 0.43,
    "weightedaveragenumberofsharesoutstandingbasic": 52703467,
    "weightedaveragenumberofdilutedsharesoutstanding": 52989030,
    "comprehensiveincomenetoftax": 22806000,
    "sharesoutstanding": 52999680,
    "stockissuedduringperiodsharesstockoptionsexercised": 70001,
    "stockissuedduringperiodvaluenewissues": 221000,
    "stockissuedduringperiodsharesnewissues": 144476,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 7932000,
    "stockissuedduringperiodsharesconversionofunits": 399009,
    "stockissuedduringperiodvalueconversionofunits": 1000,
    "depreciationdepletionandamortization": 367000,
    "noncashleasecost": 969000,
    "sharebasedcompensation": 7932000,
    "gainslossesonextinguishmentofdebt": 3600000,
    "increasedecreaseincollaborationreceivablerelatedpartycurrentandnoncurrent": 95742000,
    "increasedecreaseinotherreceivables": 461000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 799000,
    "increasedecreaseinotheroperatingassets": 1000,
    "increasedecreaseinaccountspayable": 761000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": -2416000,
    "increasedecreaseindeferredrevenue": 29009000,
    "increasedecreaseinothernoncurrentliabilities": -9000,
    "increasedecreaseinoperatingleaseliabilities": -1104000,
    "increasedecreaseinaccruedincometaxespayable": 387000,
    "netcashprovidedbyusedinoperatingactivities": -32995000,
    "proceedsfromissuanceofcommonstock": 221000,
    "netcashprovidedbyusedinfinancingactivities": 221000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -32774000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 76333000,
    "incometaxespaid": 2212000,
    "entityincorporationmonthandyear": "2013-12",
    "businessacquisitiondateofacquisitionagreement1": "2017-06-30",
    "concentrationriskcreditriskfinancialinstrumentsoffbalancesheetrisk": "As of December 31, 2023, and 2022, the Company had no off-balance sheet risks, including but not limited to, foreign exchange contracts, option contracts, or other hedging arrangements.",
    "propertyplantandequipmentusefullife": "P5Y",
    "propertyplantandequipmentestimatedusefullive": "Shorter of life of lease or 5 years",
    "cashandcashequivalentsfairvaluedisclosure": 75628000,
    "propertyplantandequipmentgross": 1636000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 3618000,
    "operatingleasesexpirationdate": "2027-07",
    "areaofrealestateproperty": 23400,
    "operatingleasecost": 1048000,
    "variableleasecost": 12000,
    "leasecost": 1626000,
    "operatingleasepayments": 1690000,
    "operatingandfinanceleaseassets": 4155000,
    "operatingleaseliability": 5543000,
    "operatingleaseweightedaverageremainingleaseterm1": "P3Y7M6D",
    "operatingleaseweightedaveragediscountratepercent": 0.098,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 1718000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 1746000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 1956000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 1156000,
    "lesseeoperatingleaseliabilitypaymentsdue": 6576000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 1033000,
    "employeerelatedliabilitiescurrent": 3339000,
    "accruedexternalresearchanddevelopmentexpensescurrent": 2274000,
    "accruedprofessionalfeescurrent": 708000,
    "otheraccruedliabilitiescurrent": 236000,
    "sharesissuedpricepershare": 1.58,
    "proceedsfromissuancefollowonpublicofferinggross": 200000,
    "convertiblepreferredstocksharesissueduponconversion": 1000,
    "maximumpercentageofcommonstockholdinguponconversionofpreferredstock": 0.0999,
    "preferredstockvotingrights": "no",
    "preferredstockconversionbasis": "The shares of Series D Preferred Stock were convertible on a one-to-one basis into shares of common stock at any time at the option of the holder, provided that the holder was prohibited from converting the Series D Preferred Stock into shares of common stock if, as a result of such conversion, the holder, together with its affiliates, would own more than 9.99% of the total number of shares of common stock then issued and outstanding, subject to certain exceptions",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P3Y14D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 14845127,
    "unrecognizedcompensationexpense": 10300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestequalmonthlyinstallments": 4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardrighttoreceivesharenumber": 1,
    "commonstockcapitalsharesreservedforfutureissuance": 5239058,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 46413,
    "allocatedsharebasedcompensationexpense": 100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 329008,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.29,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 4500000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y7M2D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 2569421,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 1109824,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 369781,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.907,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 2865594,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 2403190,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 10.89,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 1.74,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 1.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 10.88,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 10.89,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 10.29,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P5Y9M3D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P5Y9M3D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P5Y5M8D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 1000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 1000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 2.45,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 7.31,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitedweightedaveragegrantdatefairvalue": 6.8,
    "supplementaldeferredpurchaseprice": 125000000,
    "paymentsforrestructuring": 409000,
    "restructuringreservesettledwithoutcash2": 39000,
    "othertaxexpensebenefit": 2600000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 235900000,
    "operatinglosscarryforwards": 94700000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 90900000,
    "researchanddevelopmentarrangementwithfederalgovernmentcostsincurrednet": 7100000,
    "operatinglosscarryforwardsexpirationyear": 2033,
    "deferredtaxassetsoperatinglosscarryforwardsforeign": 4600000,
    "deferredtaxassetstaxcreditcarryforwardsresearchanddevelopment": 6000000,
    "statetaxcreditcarryforward": 2100000,
    "taxcreditcarryforwardexpirationperiod": 2033,
    "ownershipchangeincreaseinownershipbymaximumpercentage": 0.5,
    "ownershipchangeincreaseinownershippercentageterm": "P3Y",
    "currentfederaltaxexpensebenefit": 2488000,
    "currentstateandlocaltaxexpensebenefit": 110000,
    "currentincometaxexpensebenefit": 2598000,
    "provisionforincometaxes": 2598000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": 25404000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": 25404000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.049,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.004,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": 0.085,
    "effectiveincometaxratereconciliationnondeductibleexpenseother": 0.003,
    "effectiveincometaxratereconciliationtaxcontingenciesother": -0.01,
    "effectiveincometaxratereconciliationdeductions": 0.139,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.272,
    "effectiveincometaxratecontinuingoperations": 0.102,
    "deferredtaxassetsoperatinglosscarryforwards": 25646000,
    "deferredtaxassetsgsklicenses": 47014000,
    "deferredtaxassetstaxcreditcarryforwards": 7612000,
    "deferredtaxassetscapitalizedexpenses": 21342000,
    "deferredtaxassetsother": 6264000,
    "deferredtaxassetsgross": 107878000,
    "deferredtaxassetsvaluationallowance": 107878000,
    "valuationallowancedeferredtaxassetincreaseinamount": -6912000,
    "potentialamountadditionalfundingawarded": 10000000,
    "potentialamountincreaseincommittedfunding": 2300000,
    "potentialgrantamountawarded": 12700000,
    "maximumpotentialfundingfromgovernmentcontract": 69700000,
    "potentialgrantamountexercised": 12700000,
    "numberofoptionperiodforfundingfromgovernmentcontract": 1,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsimpairmentlosses": 5300000,
    "licenseagreementmilestonepaymentsuponachievementofspecifiedcommercialmilestone": 6400000,
    "contractterminationperiod": "P10Y",
    "contractterminationperiodifnomaterialdevelopmentorcommercializationoccurs": "P1Y",
    "remainingsublicencefeepaidtocounterparty": 900000,
    "periodofoptiongrantedonagreement": "P12M",
    "licenseagreementfuturemilestonepayments": 1000000,
    "receivableamountuponachievementofcertainmilestone": 59500000,
    "totalmilestone": 95000000,
    "milestoneachievementresearchanddevelopmentservices": 64700000,
    "additionalmilestonepaymentsreceivableuponachievementofcertaindevelopmentalregulatoryandsalesmilestone": 80000000,
    "separateaccountliabilitypremium": 12500000,
    "remainingtransactionpriceallocatedtoperformanceobligations": 64700000,
    "milestonepaymentuponsubmissionofanewdrugapplication": 23800000,
    "performanceobligationallocatedtransactionprice": 95800000,
    "totalreceivedmilestone": 95000000,
    "significantfinancingcomponent": 2500000,
    "milestoneallocatedresearchanddevelopmentservices": 8800000,
    "totalpotentialadditionalmilestones": 3200000,
    "salesmilestoneevents": 1000000000,
    "weightedaveragenumberdilutedsharesoutstandingadjustment": 285563,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 3485373,
    "definedcontributionplanemployerdiscretionarycontributionamount": 300000
  },
  {
    "date": "2022-12-30",
    "symbol": "SPRO",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "security12btitle": "Common Stock, $0.001 par value per share",
    "tradingsymbol": "SPRO",
    "securityexchangename": "The Nasdaq Global Select Market",
    "entityregistrantname": "SPERO THERAPEUTICS, INC.",
    "entitycentralindexkey": 1701108,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entitypublicfloat": 22000000,
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityshellcompany": "false",
    "entityfilenumber": "001-38266",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "46-4590683",
    "entityaddressaddressline1": "675 Massachusetts Avenue,",
    "entityaddressaddressline2": "14th Floor",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "Massachusetts",
    "entityaddresspostalzipcode": 2139,
    "cityareacode": 857,
    "localphonenumber": "242-1600",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "false",
    "auditorname": "PricewaterhouseCoopers LLP",
    "auditorlocation": "Boston, Massachusetts",
    "auditorfirmid": 238,
    "cashandcashequivalentsatcarryingvalue": 109107000,
    "otherreceivables": 1084000,
    "prepaidexpenseandotherassetscurrent": 3379000,
    "assetscurrent": 113570000,
    "propertyplantandequipmentnet": 368000,
    "operatingleaserightofuseasset": 5124000,
    "otherassetsnoncurrent": 5740000,
    "assets": 124802000,
    "accountspayablecurrent": 617000,
    "accruedexpensesandothercurrentliabilities": 8973000,
    "operatingleaseliabilitycurrent": 1690000,
    "deferredrevenuecurrent": 13900000,
    "liabilitiescurrent": 21649000,
    "operatingleaseliabilitynoncurrent": 4957000,
    "deferredrevenuenoncurrent": 22166000,
    "derivativeliabilities": 54485000,
    "otherlongtermdebtnoncurrent": 96000,
    "liabilities": 48868000,
    "commonstockvalue": 52000,
    "additionalpaidincapitalcommonstock": 489760000,
    "retainedearningsaccumulateddeficit": -413878000,
    "stockholdersequity": -413878000,
    "liabilitiesandstockholdersequity": 124802000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "grantrevenue": 4930000,
    "revenuefromcontractwithcustomerexcludingassessedtax": 1800000,
    "typeofrevenueextensiblelist": "http://fasb.org/us-gaap/2022#LicenseMember",
    "revenues": 1700000,
    "researchanddevelopmentexpense": 47593000,
    "generalandadministrativeexpense": 36483000,
    "restructuringcharges": 7270000,
    "operatingexpenses": 95706000,
    "operatingincomeloss": -42197000,
    "investmentincomeinterest": 1106000,
    "othernonoperatingincomeexpense": -55000,
    "interestexpenserelatedtothesaleoffutureroyalties": -2605000,
    "lossonextinguishmentofliabilityrelatedtothesaleoffutureroyalties": 3581000,
    "derivativegainlossonderivativenet": 917000,
    "nonoperatingincomeexpense": -4218000,
    "profitloss": -46415000,
    "earningspersharebasic": -1.23,
    "earningspersharediluted": -1.23,
    "weightedaveragenumberofsharesoutstandingbasic": "null",
    "weightedaveragenumberofdilutedsharesoutstanding": "null",
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": 2000,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": 2000,
    "comprehensiveincomenetoftax": -46413000,
    "sharesoutstanding": "null",
    "stockissuedduringperiodvaluestockoptionsexercised": 420000,
    "stockissuedduringperiodsharesstockoptionsexercised": 56120,
    "stockissuedduringperiodvaluenewissues": 27500000,
    "stockissuedduringperiodsharesnewissues": "null",
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 3000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": "null",
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 9123000,
    "issuanceofcommonstockuponthevestingofrsus": 226043,
    "commonstockissueddiscountvalue": 1300000,
    "depreciationdepletionandamortization": 700000,
    "noncashleasecost": 678000,
    "assetimpairmentcharges": 635000,
    "sharebasedcompensation": 5445000,
    "foreigncurrencytransactiongainlossbeforetax": -10000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -13000,
    "gainlossonsaleofderivatives": 100000,
    "noncashinterestexpenseassociatedwiththesaleoffutureroyalties": 2605000,
    "gainslossesonextinguishmentofdebt": -3581000,
    "increasedecreaseinotherreceivables": -1196000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -5242000,
    "increasedecreaseintaxincentivesreceivable": -351000,
    "increasedecreaseinotheroperatingassets": 3000,
    "increasedecreaseinaccountspayable": -484000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": -5377000,
    "increasedecreaseindeferredrevenue": 21892000,
    "increasedecreaseinothernoncurrentliabilities": -42000,
    "increasedecreaseinoperatingleaseliabilities": -688000,
    "netcashprovidedbyusedinoperatingactivities": -7731000,
    "paymentstoacquiremarketablesecurities": 26970000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 60777000,
    "netcashprovidedbyusedininvestingactivities": 33807000,
    "repaymentofliabilityrelatedtothesaleoffutureroyalties": 54485000,
    "proceedsfromissuanceofcommonstock": 40000000,
    "proceedsfromstockoptionsexercised": 420000,
    "netcashprovidedbyusedinfinancingactivities": -29553000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -3477000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 109107000,
    "entityincorporationmonthandyear": "December 2013",
    "businessacquisitiondateofacquisitionagreement1": "June 30, 2017",
    "milestonepaymentuponsubmissionofanewdrugapplication": 34000000,
    "concentrationriskcreditriskfinancialinstrumentsoffbalancesheetrisk": "As of December 31, 2022, and 2021, the Company had no off-balance sheet risk such as foreign exchange contracts, option contracts, or other hedging arrangements.",
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "percentageoftaxbenefitrecognized": 0.5,
    "propertyplantandequipmentusefullife": 5,
    "propertyplantandequipmentestimatedusefullive": "Shorter of life of lease or 5 years",
    "cashandcashequivalentsfairvaluedisclosure": 900000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "propertyplantandequipmentgross": 3620000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 3252000,
    "operatingleasesexpirationdate": "July 2027",
    "areaofrealestateproperty": 23400,
    "operatingleasecost": 772000,
    "variableleasecost": 59000,
    "leasecost": 1711000,
    "operatingleasepayments": 1514000,
    "financeleaserightofuseassetstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet",
    "financeleaserightofuseasset": 201000,
    "operatingandfinanceleaseassets": 5325000,
    "operatingleaseliability": 6647000,
    "operatingleaseweightedaverageremainingleaseterm1": 4.6,
    "operatingleaseweightedaveragediscountratepercent": 0.098,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 1690000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 1718000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 1746000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 1956000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 1156000,
    "lesseeoperatingleaseliabilitypaymentsdue": 8266000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 1619000,
    "accruedexternalresearchanddevelopmentexpensescurrent": 1823000,
    "employeerelatedliabilitiescurrent": 5797000,
    "accruedprofessionalfeescurrent": 696000,
    "accruedrestructuringexpenses": 448000,
    "otheraccruedliabilitiescurrent": 209000,
    "sharesissuedpricepershare": 16.93,
    "proceedsfromissuancefollowonpublicofferinggross": 14700000,
    "convertiblepreferredstocksharesissueduponconversion": 1000,
    "maximumpercentageofcommonstockholdinguponconversionofpreferredstock": 0.0999,
    "preferredstockliquidationpreference": 0.001,
    "preferredstockvotingrights": "no",
    "preferredstockconversionbasis": "The shares of Series D Preferred Stock are convertible on a one-to-one basis into shares of common stock at any time at the option of the holder, provided that the holder will be prohibited from converting the Series D Preferred Stock into shares of common stock if, as a result of such conversion, the holder, together with its affiliates, would own more than 9.99% of the total number of shares of common stock then issued and outstanding, subject to certain exceptions.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": 2.83,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": "null",
    "unrecognizedcompensationexpense": 8100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestequalmonthlyinstallments": 4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardrighttoreceivesharenumber": 1,
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "allocatedsharebasedcompensationexpense": 1000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 226043,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.88,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 11400000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.42,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 408000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.017,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.8270000000000001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 10.99,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 11.12,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 7.48,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 13.21,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 10.99,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 9.76,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 5.27,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 5.27,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": 4.58,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 1000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 1000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 7.51,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitedweightedaveragegrantdatefairvalue": 14.16,
    "supplementaldeferredpurchaseprice": 125000000,
    "additionalinvestmentamount": 50000000,
    "alternativeinvestment": 25000000,
    "costsandexpensesrelatedparty": 200000000,
    "relatedpartytransactionpurchasesfromrelatedparty": 10000000,
    "relatedpartytransactionrate": 0.03,
    "changeofcontrolvalueinexcessamount": 200000000,
    "paymentforroyaltyliabilities": 3581000,
    "establishchangeofcontrolderivativeliability": -115000,
    "royaltyexpense": 2605000,
    "businesscombinationintegrationrelatedcosts": 8600000,
    "liabilitiessubjecttocompromiseearlycontractterminationfees": 3000000,
    "outstandingaccruedexpense": 400000,
    "severancecosts1": 8552000,
    "otherrestructuringcosts": 3078000,
    "restructuringreserve": 448000,
    "paymentsforrestructuring": 7702000,
    "restructuringreservesettledwithoutcash2": 3480000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 291900000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 282900000,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 73000000,
    "operatinglosscarryforwardsexpirationyear": 2039,
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 218900000,
    "deferredtaxassetsoperatinglosscarryforwardsforeign": 4600000,
    "deferredtaxassetstaxcreditcarryforwardsresearchanddevelopment": 11500000,
    "statetaxcreditcarryforward": -2800000,
    "taxcreditcarryforwardexpirationperiod": 2028,
    "ownershipchangeincreaseinownershipbymaximumpercentage": 0.5,
    "ownershipchangeincreaseinownershippercentageterm": "three-year",
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "deferredtaxliabilitiesdeferredexpensecapitalizedresearchanddevelopmentcosts": 47600000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -46249000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -166000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -46415000,
    "effectiveincometaxratereconciliationtaxcreditsresearch": -0.043,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.023,
    "effectiveincometaxratereconciliationnondeductibleexpense": 0.01,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.266,
    "deferredtaxassetsoperatinglosscarryforwards": 78619000,
    "deferredtaxassetstaxcreditcarryforwards": 14294000,
    "deferredtaxassetsother": 10264000,
    "deferredtaxassetsgross": 114790000,
    "deferredtaxassetsvaluationallowance": 114790000,
    "valuationallowancedeferredtaxassetincreaseinamount": 12346000,
    "potentialamountadditionalfundingawarded": 100000,
    "potentialamountincreaseincommittedfunding": 2200000,
    "maximumpotentialfundingfromgovernmentcontract": 23500000,
    "potentialgrantamountexercised": 12700000,
    "proceedsfromgovernmentcontract": 4000000,
    "licenseagreementmilestonepaymentsuponachievementofspecifiedcommercialmilestone": 6000000,
    "contractterminationperiod": "ten years",
    "contractterminationperiodifnomaterialdevelopmentorcommercializationoccurs": "one year",
    "sublicensefeepayabletocounterparty": 7500000,
    "sublicencefeepaidtocounterparty": 6600000,
    "periodofoptiongrantedonagreement": 12,
    "licenseagreementmilestonepaymentuponcompletionanddeliveryofresultsofclinicalstudy": 1000000,
    "licenseagreementfuturemilestonepayments": 1000000,
    "receivableamountuponachievementofcertainmilestone": 59500000,
    "transactionpriceallocatedtoperformanceobligations": 64700000,
    "initialpaymentstoperformtheobligations": 66000000,
    "discountonobligations": 1300000,
    "serviceagreementadditionalpaymentrelatedtofacilitybuildoutcosts": 5300000,
    "additionalmilestonepaymentsreceivableuponachievementofcertaindevelopmentalregulatoryandsalesmilestone": 80000000,
    "separateaccountliabilitypremium": 12500000,
    "remainingtransactionpriceallocatedtoperformanceobligations": 12500000,
    "performanceobligationallocatedtransactionprice": 11100000,
    "salesmilestoneevents": 1000000000,
    "netincomelossavailabletocommonstockholdersbasic": 46415000,
    "definedcontributionplanemployerdiscretionarycontributionamount": 400000
  },
  {
    "date": "2021-12-30",
    "symbol": "SPRO",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "security12btitle": "Common Stock, $0.001 par value per share",
    "tradingsymbol": "SPRO",
    "securityexchangename": "The Nasdaq Global Select Market",
    "entityregistrantname": "SPERO THERAPEUTICS, INC.",
    "entitycentralindexkey": 1701108,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "true",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityshellcompany": "false",
    "entityfilenumber": "001-38266",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "46-4590683",
    "entityaddressaddressline1": "675 Massachusetts Avenue,",
    "entityaddressaddressline2": "14th Floor",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "Massachusetts",
    "entityaddresspostalzipcode": 2139,
    "cityareacode": 857,
    "localphonenumber": "242-1600",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "false",
    "auditorname": "PricewaterhouseCoopers LLP",
    "auditorlocation": "Boston, Massachusetts",
    "auditorfirmid": 238,
    "cashandcashequivalentsatcarryingvalue": 112584000,
    "marketablesecuritiescurrent": 33818000,
    "otherreceivables": 2280000,
    "taxincentivereceivablecurrent": 361000,
    "prepaidexpenseandotherassetscurrent": 8829000,
    "assetscurrent": 157872000,
    "propertyplantandequipmentnet": 1026000,
    "operatingleaserightofuseasset": 6530000,
    "otherassetsnoncurrent": 5644000,
    "assets": 171072000,
    "accountspayablecurrent": 1101000,
    "accruedexpensesandothercurrentliabilities": 14350000,
    "operatingleaseliabilitycurrent": 1362000,
    "deferredrevenuecurrent": 1857000,
    "derivativeliabilities": 1000000,
    "liabilitiescurrent": 18670000,
    "accruedroyaltiescurrentandnoncurrent": 48414000,
    "operatingleaseliabilitynoncurrent": 5973000,
    "deferredrevenuenoncurrent": 8786000,
    "otherlongtermdebtnoncurrent": 138000,
    "liabilities": 82783000,
    "preferredstockvalue": 3000,
    "commonstockvalue": 32000,
    "additionalpaidincapitalcommonstock": 455719000,
    "retainedearningsaccumulateddeficit": -367463000,
    "accumulatedothercomprehensiveincomelossnetoftax": -2000,
    "stockholdersequity": -2000,
    "liabilitiesandstockholdersequity": 171072000,
    "preferredstocksharesauthorized": "null",
    "preferredstocksharesissued": "null",
    "preferredstocksharesoutstanding": "null",
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": 9252,
    "commonstocksharesoutstanding": "null",
    "grantrevenue": 15186000,
    "revenuefromcontractwithcustomerexcludingassessedtax": 1800000,
    "typeofrevenueextensiblelist": "http://fasb.org/us-gaap/2021-01-31#LicenseMember",
    "revenues": 400000,
    "researchanddevelopmentexpense": 64526000,
    "generalandadministrativeexpense": 41701000,
    "operatingexpenses": 106227000,
    "operatingincomeloss": -87971000,
    "investmentincomeinterest": 346000,
    "othernonoperatingincomeexpense": -395000,
    "interestexpenserelatedtothesaleoffutureroyalties": -1940000,
    "derivativegainlossonderivativenet": 204000,
    "nonoperatingincomeexpense": -1785000,
    "profitloss": -89756000,
    "earningspersharebasicanddiluted": -2.91,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": "null",
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": 5000,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": 5000,
    "comprehensiveincomenetoftax": -89751000,
    "sharesoutstanding": "null",
    "stockissuedduringperiodvaluestockoptionsexercised": 1450000,
    "stockissuedduringperiodsharesstockoptionsexercised": 160674,
    "stockissuedduringperiodvaluenewissues": 27500000,
    "stockissuedduringperiodsharesnewissues": "null",
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 135000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 9430000,
    "paymentsofstockissuancecosts": 248000,
    "paymentsoffinancingcosts": 200000,
    "commonstockissuedpremiumvalue": 12500000,
    "depreciationdepletionandamortization": 646000,
    "noncashleasecost": 471000,
    "sharebasedcompensation": 5267000,
    "foreigncurrencytransactiongainlossbeforetax": -13000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -251000,
    "gainlossonsaleofderivatives": 204000,
    "noncashinterestexpenseassociatedwiththesaleoffutureroyalties": 1940000,
    "increasedecreaseinotherreceivables": -3050000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 2808000,
    "increasedecreaseintaxincentivesreceivable": -782000,
    "increasedecreaseinotheroperatingassets": 319000,
    "increasedecreaseinaccountspayable": -53000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 2109000,
    "increasedecreaseindeferredrevenue": 10643000,
    "increasedecreaseinothernoncurrentliabilities": -39000,
    "increasedecreaseinoperatingleaseliabilities": -503000,
    "netcashprovidedbyusedinoperatingactivities": -64347000,
    "paymentstoacquiremarketablesecurities": 43915000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 51548000,
    "paymentsforproceedsfrompropertyandequipment": -39000,
    "netcashprovidedbyusedininvestingactivities": 7672000,
    "proceedsfromissuanceofcommonstock": 3700000,
    "proceedsfromsaleoffutureroyaltiesnet": 49750000,
    "transactioncostsfromsaleoffutureroyalties": -2210000,
    "royaltypayments": 60000,
    "proceedsfromstockoptionsexercised": 1450000,
    "netcashprovidedbyusedinfinancingactivities": 84050000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 27375000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 112584000,
    "entityincorporationmonthandyear": "December 2013",
    "businessacquisitiondateofacquisitionagreement1": "June 30, 2017",
    "authorizedcommonstockvalueavailableforissuance": 344205,
    "netincomeloss": -89800000,
    "concentrationriskcreditriskfinancialinstrumentsoffbalancesheetrisk": "As of December 31, 2021, and 2020, the Company had no off-balance sheet risk such as foreign exchange contracts, option contracts, or other hedging arrangements.",
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "January 1, 2020",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "caresactnetoperatinglosscarrybackperiod": "five years",
    "caresacteliminatedpercentageonlimitationoftaxableincome": 0.8,
    "caresactpercentageofadjustedtaxableincomeplusbusinessinterestincome": 0.5,
    "caresactpercentageoflimitationonadjustedtaxableincomeplusbusinessinterestincomeundertaxcutandjobsact2017": 0.3,
    "caresactcharitabledeductiondescription": "CARES Act raises the corporate charitable deduction limit to 25% of taxable income and makes qualified improvement property generally eligible for 15-year cost-recovery and 100% bonus depreciation.",
    "percentageoftaxbenefitrecognized": 0.5,
    "propertyplantandequipmentusefullife": 5,
    "propertyplantandequipmentestimatedusefullives": "Shorter of life of lease or 5 years",
    "cashandcashequivalentsfairvaluedisclosure": 600000,
    "investmentsfairvaluedisclosure": 33818000,
    "assetsfairvaluedisclosure": 145835000,
    "liabilitiesfairvaluedisclosure": 802000,
    "percentofaggregatepaymentreceived": 2.5,
    "royaltyguaranteescommitmentsamount": 1000000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "availableforsaledebtsecuritiesamortizedcostbasis": 33820000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 2000,
    "availableforsalesecuritiesdebtsecurities": 33818000,
    "propertyplantandequipmentgross": 3906000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 2880000,
    "lesseeoperatingleaseoptiontoextend": "the Company has two consecutive options to extend the Lease Term for an additional period of five years (the “Option Terms”), subject to certain conditions, upon notice to the Landlord.",
    "financeleaseliabilitystatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentNet",
    "operatingleasecost": 681000,
    "variableleasecost": 143000,
    "leasecost": 1769000,
    "operatingleasepayments": 1525000,
    "financeleaserightofuseasset": 468000,
    "financeleaserightofuseassetstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentNet",
    "operatingandfinanceleaseassets": 6998000,
    "operatingleaseliability": 7335000,
    "operatingleaseweightedaverageremainingleaseterm1": 5.6,
    "operatingleaseweightedaveragediscountratepercent": 0.098,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 1362000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 1690000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 1718000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 1746000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 1956000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 1155000,
    "lesseeoperatingleaseliabilitypaymentsdue": 9627000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 2292000,
    "accruedexternalresearchanddevelopmentexpensescurrent": 6315000,
    "employeerelatedliabilitiescurrent": 5884000,
    "accruedprofessionalfeescurrent": 909000,
    "otheraccruedliabilitiescurrent": 1242000,
    "sharesissuedpricepershare": 16.93,
    "amountofagreedpurchasesharesandnotsubscribedsharesvalueunderrightsoffering": 30000000,
    "convertiblepreferredstocksharesissueduponconversion": 1000,
    "maximumpercentageofcommonstockholdinguponconversionofpreferredstock": 0.0999,
    "preferredstockliquidationpreference": 0.001,
    "preferredstockvotingrights": "no",
    "preferredstockconversionbasis": "The shares of Series D Preferred Stock are convertible on a one-to-one basis into shares of common stock at any time at the option of the holder, provided that the holder will be prohibited from converting the Series D Preferred Stock into shares of common stock if, as a result of such conversion, the holder, together with its affiliates, would own more than 9.99% of the total number of shares of common stock then issued and outstanding, subject to certain exceptions.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": 3.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": "null",
    "unrecognizedcompensationexpense": 8100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestequalmonthlyinstallments": 4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardrighttoreceivesharenumber": 1,
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 516790,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 17.06,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 2300000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 25300000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 513690,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 339552,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 3100,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.008,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.9259999999999999,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 11.75,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 17.62,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 9.02,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 13.81,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 11.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 8.54,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 7.62,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 7.62,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": 6.44,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 24263000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 24263000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 18904000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 17.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitedweightedaveragegrantdatefairvalue": 14.41,
    "supplementaldeferredpurchaseprice": 125000000,
    "initialinvestmentamount": 13500,
    "hardcapitalamount": 250000000,
    "investmentamountfunded": 312500000,
    "percentageofannualnetrevenues": 0.015,
    "percentofminimumaggregatepaymentreceivedthreshold": 1,
    "dateofminimumaggregatepaymentreceivedthreshold": "September 30, 2027",
    "proceedsfromroyaltiesreceived": 50000000,
    "royaltyissuancecost": -2460000,
    "debtinstrumentinterestrateduringperiod": 0.20800000000000002,
    "percentageofconditionalobligation": 2.5,
    "paymentforroyaltyliabilities": -60000,
    "royaltyexpense": 1940000,
    "royaltyliabilityendingbalance": 48414000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 303700000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 302600000,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 73000000,
    "operatinglosscarryforwardsexpirationyear": 2039,
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 230700000,
    "deferredtaxassetsoperatinglosscarryforwardsforeign": 4400000,
    "deferredtaxassetstaxcreditcarryforwardsresearchanddevelopment": 2200000,
    "taxcreditcarryforwardexpirationperiod": 2028,
    "ownershipchangeincreaseinownershipbymaximumpercentage": 0.5,
    "ownershipchangeincreaseinownershippercentageterm": "three-year",
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -89565000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -191000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -89756000,
    "effectiveincometaxratereconciliationtaxcreditsresearch": -0.031000000000000003,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.07,
    "effectiveincometaxratereconciliationnondeductibleexpense": 0.006,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.305,
    "deferredtaxassetsoperatinglosscarryforwards": 83849000,
    "deferredtaxassetstaxcreditcarryforwards": 12375000,
    "deferredtaxassetsother": 6220000,
    "deferredtaxassetsgross": 102444000,
    "deferredtaxassetsvaluationallowance": 102444000,
    "valuationallowancedeferredtaxassetincreaseinamount": 27405000,
    "potentialamountadditionalfundingawarded": 10000000,
    "maximumpotentialfundingfromgovernmentcontract": 9700000,
    "potentialgrantamountexercised": 12700000,
    "numberofoptionperiodforfundingfromgovernmentcontract": 2,
    "proceedsfromgovernmentcontract": 5900000,
    "licenseagreementmilestonepaymentsuponachievementofspecifiedcommercialmilestone": 6700000,
    "contractterminationperiod": "ten years",
    "contractterminationperiodifnomaterialdevelopmentorcommercializationoccurs": "one year",
    "sublicensefeepayabletocounterparty": 7500000,
    "periodofoptiongrantedonagreement": 12,
    "licenseagreementmilestonepaymentuponcompletionanddeliveryofresultsofclinicalstudy": 1000,
    "licenseagreementfuturemilestonepayments": 1000,
    "receivableamountuponachievementofcertainmilestone": 59500000,
    "upfrontlicensefee": 2000000,
    "transactionpriceallocatedtoperformanceobligations": 5000000,
    "performanceobligationsexclusiveoptiontonegotiatelicense": 1000000,
    "performanceobligationsrelatedtoresearchanddevelopmentservicesmilestone": 2000000,
    "reductiontoresearchanddevelopmentexpense": 1500000,
    "serviceagreementadditionalpaymentrelatedtofacilitybuildoutcosts": 5200000,
    "additionalmilestonepaymentsreceivableuponachievementofcertaindevelopmentalregulatoryandsalesmilestone": 80000000,
    "separateaccountliabilitypremium": 12500000,
    "remainingtransactionpriceallocatedtoperformanceobligations": 10600000,
    "performanceobligationallocatedtransactionprice": 12500000,
    "effectivetaxincentiveraterelatedtoresearchanddevelopment": 0.435,
    "taxincentiveresearchanddevelopmentactivities": 100000,
    "taxincentivereceivable": 400000,
    "netincomelossavailabletocommonstockholdersbasic": -89756000,
    "definedcontributionplanemployerdiscretionarycontributionamount": 500000,
    "saleofstockpricepershare": 10.86
  },
  {
    "date": "2020-12-30",
    "symbol": "SPRO",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2020",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "security12btitle": "Common Stock, $0.001 par value per share",
    "tradingsymbol": "SPRO",
    "securityexchangename": "The Nasdaq Global Select Market",
    "entityregistrantname": "SPERO THERAPEUTICS, INC.",
    "entitycentralindexkey": 1701108,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "true",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityshellcompany": "false",
    "entityfilenumber": "001-38266",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "46-4590683",
    "entityaddressaddressline1": "675 Massachusetts Avenue,",
    "entityaddressaddressline2": "14th  Floor",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "Massachusetts",
    "entityaddresspostalzipcode": 2139,
    "cityareacode": 857,
    "localphonenumber": "242-1600",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "false",
    "cashandcashequivalentsatcarryingvalue": 85209000,
    "marketablesecuritiescurrent": 41697000,
    "otherreceivables": 5330000,
    "taxincentivereceivablecurrent": 846000,
    "prepaidexpenseandotherassetscurrent": 6063000,
    "assetscurrent": 139145000,
    "propertyplantandequipmentnet": 1669000,
    "taxincentivereceivablenoncurrent": 311000,
    "operatingleaserightofuseasset": 7114000,
    "otherassetsnoncurrent": 5212000,
    "assets": 153451000,
    "accountspayablecurrent": 1155000,
    "accruedexpensesandothercurrentliabilities": 12241000,
    "operatingleaseliabilitycurrent": 947000,
    "liabilitiescurrent": 14343000,
    "operatingleaseliabilitynoncurrent": 6891000,
    "otherlongtermdebtnoncurrent": 177000,
    "liabilities": 21411000,
    "preferredstockvalue": 3000,
    "commonstockvalue": 29000,
    "additionalpaidincapitalcommonstock": 409722000,
    "retainedearningsaccumulateddeficit": -277707000,
    "accumulatedothercomprehensiveincomelossnetoftax": -7000,
    "stockholdersequity": 132040000,
    "liabilitiesandstockholdersequity": 153451000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": "null",
    "preferredstocksharesissued": "null",
    "preferredstocksharesoutstanding": "null",
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "grantrevenue": 9072000,
    "revenuefromcontractwithcustomerexcludingassessedtax": 300000,
    "typeofrevenueextensiblelist": "us-gaap:LicenseMember",
    "revenues": 700000,
    "researchanddevelopmentexpense": 67003000,
    "generalandadministrativeexpense": 21440000,
    "operatingexpenses": 88443000,
    "operatingincomeloss": -79113000,
    "investmentincomeinterest": 401000,
    "othernonoperatingincomeexpense": 432000,
    "nonoperatingincomeexpense": 833000,
    "profitloss": -78280000,
    "earningspersharebasicanddiluted": -3.52,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": "null",
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -23000,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": -23000,
    "comprehensiveincomenetoftax": -78303000,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": 132040000,
    "sharesoutstanding": "null",
    "stockissuedduringperiodvaluestockoptionsexercised": 2189000,
    "stockissuedduringperiodsharesstockoptionsexercised": 324433,
    "stockissuedduringperiodvaluenewissues": 30221000,
    "stockissuedduringperiodsharesnewissues": 993870,
    "beneficialconversionfeatureofstock": 549000,
    "deemeddividendsrelatedtoimmediateaccretionofbeneficialconversionfeatureofstock": -549000,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": -2000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": "null",
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 4888000,
    "paymentsofstockissuancecosts": 953000,
    "depreciationdepletionandamortization": 761000,
    "noncashleasecost": 585000,
    "sharebasedcompensation": 2659000,
    "foreigncurrencytransactiongainlossbeforetax": 330000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 32000,
    "increasedecreaseinotherreceivables": -2430000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 1240000,
    "increasedecreaseintaxincentivesreceivable": 254000,
    "increasedecreaseinotheroperatingassets": 1890000,
    "increasedecreaseinaccountspayable": -2975000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": -9130000,
    "increasedecreaseinothernoncurrentliabilities": -72000,
    "increasedecreaseinoperatingleaseliabilities": -333000,
    "netcashprovidedbyusedinoperatingactivities": -85872000,
    "paymentstoacquiremarketablesecurities": 45723000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 56350000,
    "paymentstoacquirepropertyplantandequipment": 157000,
    "netcashprovidedbyusedininvestingactivities": 10470000,
    "proceedsfromissuanceofcommonstock": 56078000,
    "proceedsfromissuanceofpreferredstockandpreferencestock": 30402000,
    "proceedsfromstockoptionsexercised": 2189000,
    "netcashprovidedbyusedinfinancingactivities": 130881000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 55479000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 85209000,
    "rightofuseassetsandleaseobligationsrecordeduponcommencementoramendmentofleaseagreements": 2626000,
    "entityincorporationmonthandyear": "December 2013",
    "businessacquisitiondateofacquisitionagreement1": "June 30, 2017",
    "proceedsfromissuanceofcommonstockgross": 13600,
    "netincomeloss": -78300000,
    "concentrationriskcreditriskfinancialinstrumentsoffbalancesheetrisk": "As of December 31, 2020, and 2019, the Company had no off-balance sheet risk such as foreign exchange contracts, option contracts, or other hedging arrangements.",
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "January 1, 2020",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "caresactnetoperatinglosscarrybackperiod": "five years",
    "caresacteliminatedpercentageonlimitationoftaxableincome": 0.8,
    "caresactpercentageofadjustedtaxableincomeplusbusinessinterestincome": 0.5,
    "caresactpercentageoflimitationonadjustedtaxableincomeplusbusinessinterestincomeundertaxcutandjobsact2017": 0.3,
    "propertyplantandequipmentusefullife": 5,
    "propertyplantandequipmentestimatedusefullives": "Shorter of life of lease or 5 years",
    "cashandcashequivalentsfairvaluedisclosure": 2700000,
    "investmentsfairvaluedisclosure": 41697000,
    "assetsfairvaluedisclosure": 124189000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "businessacquisitioneffectivedateofacquisition1": "January 1, 2020",
    "availableforsaledebtsecuritiesamortizedcostbasis": 41703000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 6000,
    "availableforsalesecuritiesdebtsecurities": 41697000,
    "propertyplantandequipmentgross": 3945000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 2276000,
    "lesseeoperatingleaseoptiontoextend": "the Company has two consecutive options to extend the Lease Term for an additional period of five years (the “Option Terms”), subject to certain conditions, upon notice to the Landlord.",
    "operatingleasecost": 418000,
    "variableleasecost": 58000,
    "leasecost": 1373000,
    "operatingleasepayments": 1171000,
    "noncashamountofrightofuseassetandleaseobligationincurred": 2626000,
    "financeleaserightofuseasset": 736000,
    "financeleaserightofuseassetstatementoffinancialpositionextensiblelist": "us-gaap:PropertyPlantAndEquipmentMember",
    "operatingandfinanceleaseassets": 7850000,
    "operatingleaseliability": 7838000,
    "operatingleaseweightedaverageremainingleaseterm1": "P6Y7M6D",
    "operatingleaseweightedaveragediscountratepercent": 0.098,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 947000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 1662000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 1690000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 1718000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 1746000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 3113000,
    "lesseeoperatingleaseliabilitypaymentsdue": 10876000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 3038000,
    "accruedexternalresearchanddevelopmentexpensescurrent": 7035000,
    "employeerelatedliabilitiescurrent": 3918000,
    "accruedprofessionalfeescurrent": 1066000,
    "otheraccruedliabilitiescurrent": 222000,
    "sharesissuedpricepershare": 13.66,
    "amountofagreedpurchasesharesandnotsubscribedsharesvalueunderrightsoffering": 30000000,
    "preferredstockintrinsicvalueofbeneficialconversionfeature": 500000,
    "convertiblepreferredstocksharesissueduponconversion": "null",
    "maximumpercentageofcommonstockholdinguponconversionofpreferredstock": 0.0999,
    "preferredstockliquidationpreference": 0.001,
    "preferredstockvotingrights": "no",
    "preferredstockconversionbasis": "The shares of Series D Preferred Stock are convertible on a one-to-one basis into shares of common stock at any time at the option of the holder, provided that the holder will be prohibited from converting the Series D Preferred Stock into shares of common stock if, as a result of such conversion, the holder, together with its affiliates, would own more than 9.99% of the total number of shares of common stock then issued and outstanding, subject to certain exceptions.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 481500,
    "commonstockcapitalsharesreservedforfutureissuance": 769932,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 7.79,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 2300000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 11500000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 30561,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 177290,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 10189,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.011000000000000001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.8270000000000001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 9.1,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 10.94,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 6.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 9.94,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 9.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 7.94,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y10M2D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P7Y10M2D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P6Y11M4D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 37881000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 37881000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 20286000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 228100000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 226200000,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 73000000,
    "operatinglosscarryforwardsexpirationyear": 2039,
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 155100000,
    "deferredtaxassetsoperatinglosscarryforwardsforeign": 10700000,
    "deferredtaxassetstaxcreditcarryforwardsresearchanddevelopment": 1400000,
    "taxcreditcarryforwardexpirationperiod": 2028,
    "ownershipchangeincreaseinownershipbymaximumpercentage": 0.5,
    "ownershipchangeincreaseinownershippercentageterm": "P3Y",
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -77671000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -609000,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": -78280000,
    "effectiveincometaxratereconciliationtaxcreditsresearch": -0.032,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.062000000000000006,
    "effectiveincometaxratereconciliationnondeductibleexpense": 0.009000000000000001,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.295,
    "deferredtaxassetsoperatinglosscarryforwards": 63612000,
    "deferredtaxassetstaxcreditcarryforwards": 8024000,
    "deferredtaxassetsother": 3403000,
    "deferredtaxassetsgross": 75039000,
    "deferredtaxassetsvaluationallowance": 75039000,
    "valuationallowancedeferredtaxassetincreaseinamount": 23059000,
    "potentialamountadditionalfundingawarded": 10000,
    "maximumpotentialfundingfromgovernmentcontract": 56800,
    "potentialgrantamountexercised": 12700,
    "numberofoptionperiodforfundingfromgovernmentcontract": 2,
    "proceedsfromgovernmentcontract": 5900000,
    "maximumreceivedfundamount": 1300000,
    "licenseagreementmilestonepaymentsuponachievementofspecifiedcommercialmilestone": 6800000,
    "contractterminationperiod": "ten years",
    "licenseagreementpaymentofresearchanddevelopmentexpenserelatedtoachievementofregulatorymilestones": 900000,
    "contractterminationperiodifnomaterialdevelopmentorcommercializationoccurs": "one year",
    "periodofoptiongrantedonagreement": 12,
    "upfrontpaymentreceived": 2000000,
    "receivableamountuponachievementofcertainmilestone": 59500000,
    "upfrontlicensefee": 2000000,
    "transactionpriceallocatedtoperformanceobligations": 1303000,
    "performanceobligationsexclusiveoptiontonegotiatelicense": 1000000,
    "performanceobligationsrelatedtoresearchanddevelopmentservicesmilestone": 2000000,
    "reductiontoresearchanddevelopmentexpense": 2100000,
    "serviceagreementadditionalpaymentrelatedtofacilitybuildoutcosts": 5100000,
    "performanceobligationstandalonesellingprice": 3614000,
    "revenueperformanceobligationsrecognitionmethoddescription": "Recognized over time as services are delivered through the completion date, and fully recognized as of December 31, 2020.",
    "effectivetaxincentiveraterelatedtoresearchanddevelopment": 0.435,
    "taxincentiveresearchanddevelopmentactivities": 300000,
    "taxincentivereceivable": 1200000,
    "preferredstockdividendsincomestatementimpact": 549000,
    "netincomelossavailabletocommonstockholdersbasic": -78829000,
    "preferredstockaccretionofredemptiondiscount": 500000,
    "definedcontributionplanemployerdiscretionarycontributionamount": 300000
  },
  {
    "date": "2019-12-30",
    "symbol": "SPRO",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "security12btitle": "Common Stock, $0.001 par value per share",
    "tradingsymbol": "SPRO",
    "securityexchangename": "NASDAQ",
    "entityregistrantname": "Spero Therapeutics, Inc.",
    "entitycentralindexkey": 1701108,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "true",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityshellcompany": "false",
    "entityfilenumber": "001-38266",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "46-4590683",
    "entityaddressaddressline1": "675 Massachusetts Avenue,",
    "entityaddressaddressline2": "14th  Floor",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2139,
    "cityareacode": 857,
    "localphonenumber": "242-1600",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "cashandcashequivalentsatcarryingvalue": 29730000,
    "marketablesecuritiescurrent": 52315000,
    "otherreceivables": 7760000,
    "taxincentivereceivablecurrent": 786000,
    "prepaidexpenseandotherassetscurrent": 4823000,
    "assetscurrent": 95414000,
    "propertyplantandequipmentnet": 2273000,
    "taxincentivereceivablenoncurrent": 21000,
    "operatingleaserightofuseasset": 4875000,
    "otherassetsnoncurrent": 3520000,
    "assets": 106103000,
    "accountspayablecurrent": 4147000,
    "accruedexpensesandothercurrentliabilities": 21588000,
    "operatingleaseliabilitycurrent": 928000,
    "liabilitiescurrent": 26663000,
    "operatingleaseliabilitynoncurrent": 4617000,
    "otherlongtermdebtnoncurrent": 249000,
    "liabilities": 31529000,
    "commonstockvalue": 19000,
    "additionalpaidincapitalcommonstock": 273966000,
    "retainedearningsaccumulateddeficit": -199427000,
    "accumulatedothercomprehensiveincomelossnetoftax": 16000,
    "stockholdersequity": 74574000,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": 74574000,
    "liabilitiesandstockholdersequity": 106103000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "preferredstocksharesissued": 2720,
    "preferredstocksharesoutstanding": 2720,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 60000000,
    "commonstocksharesissued": 19190695,
    "commonstocksharesoutstanding": 19190695,
    "grantrevenue": 13405000,
    "revenuefromcontractwithcustomerexcludingassessedtax": 4700000,
    "typeofrevenueextensiblelist": "us-gaap:LicenseMember",
    "revenues": 1000000,
    "researchanddevelopmentexpense": 65775000,
    "generalandadministrativeexpense": 15588000,
    "operatingexpenses": 81363000,
    "operatingincomeloss": -63216000,
    "gainlossonsaleofderivatives": 223000,
    "investmentincomeinterest": 1328000,
    "othernonoperatingincomeexpense": 740000,
    "nonoperatingincomeexpense": 2291000,
    "profitloss": -60925000,
    "earningspersharebasicanddiluted": -3.35,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 18160525,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": 38000,
    "othercomprehensiveincomelossreclassificationadjustmentfromaociforsaleofsecuritiesnetoftax": -6000,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": 44000,
    "comprehensiveincomenetoftax": -60881000,
    "sharesoutstanding": 19190695,
    "stockissuedduringperiodvaluestockoptionsexercised": 508000,
    "stockissuedduringperiodsharesstockoptionsexercised": 78610,
    "stockissuedduringperiodvaluenewissues": 15316000,
    "stockissuedduringperiodsharesnewissues": 475024,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": -1000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 500000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 3776000,
    "minorityinterestdecreasefromredemptions": 355000,
    "paymentsofstockissuancecosts": 158000,
    "depreciationdepletionandamortization": 750000,
    "noncashleasecost": 408000,
    "gainlossondispositionofassets1": -184000,
    "sharebasedcompensation": 2196000,
    "realizedinvestmentgainslosses": 1000,
    "foreigncurrencytransactiongainlossbeforetax": 18000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 750000,
    "increasedecreaseinotherreceivables": 7384000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -2654000,
    "increasedecreaseintaxincentivesreceivable": -299000,
    "increasedecreaseinotheroperatingassets": 2912000,
    "increasedecreaseinaccountspayable": 564000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 13610000,
    "increasedecreaseinothernoncurrentliabilities": -52000,
    "netcashprovidedbyusedinoperatingactivities": -50020000,
    "paymentstoacquiremarketablesecurities": 88993000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 118837000,
    "paymentstoacquirepropertyplantandequipment": 314000,
    "netcashprovidedbyusedininvestingactivities": 29530000,
    "proceedsfromissuanceofcommonstock": 15790000,
    "proceedsfromstockoptionsexercised": 508000,
    "netcashprovidedbyusedinfinancingactivities": 16140000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -4350000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 29730000,
    "entityincorporationmonthandyear": "2013-12",
    "businessacquisitiondateofacquisitionagreement1": "2017-06-30",
    "businesscombinationexchangeratio": 1,
    "netincomeloss": -60900000,
    "businessacquisitionpercentageofvotinginterestsacquired": 1,
    "repurchaseofnoncontrollinginterestpricepershare": 0.001,
    "effectivetaxincentiveraterelatedtoresearchanddevelopment": 0.435,
    "operatingleaseliability": 5545000,
    "propertyplantandequipmentusefullife": "P5Y",
    "propertyplantandequipmentestimatedusefullives": "Shorter of life of lease or 5 years",
    "cashandcashequivalentsfairvaluedisclosure": 3000000,
    "investmentsfairvaluedisclosure": 52315000,
    "assetsfairvaluedisclosure": 79066000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 5730178,
    "availableforsaledebtsecuritiesamortizedcostbasis": 52299000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 18000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 2000,
    "availableforsalesecuritiesdebtsecurities": 52315000,
    "propertyplantandequipmentgross": 3788000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 1515000,
    "assetimpairmentcharges": 200000,
    "leaseexpirationdate1": "2019-11-30",
    "lesseeoperatingleaseoptiontoextend": "the Company has two consecutive options to extend the Lease Term for an additional period of five years (the “Option Terms”), subject to certain conditions, upon notice to the Landlord.",
    "operatingleasepayments": 1234000,
    "lesseeoperatingleaseleasenotyetcommencedfutureminimumleasepayments": 4300000,
    "lesseeoperatingleaseleasenotyetcommencedexpectedtocommenceyearandmonth": "2020-06",
    "lesseeoperatingleaseleasenotyetcommencedtermofcontract1": "P7Y",
    "operatingleasecost": 641000,
    "variableleasecost": 181000,
    "leasecost": 1479000,
    "noncashamountofrightofuseassetandleaseobligationincurred": 1038000,
    "financeleaserightofuseasset": 1004000,
    "financeleaserightofuseassetstatementoffinancialpositionextensiblelist": "us-gaap:PropertyPlantAndEquipmentMember",
    "operatingandfinanceleaseassets": 5879000,
    "operatingleaseweightedaverageremainingleaseterm1": "P7Y",
    "operatingleaseweightedaveragediscountratepercent": 0.1,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 928000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 943000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 1061000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 1076000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 1092000,
    "lesseeoperatingleaseliabilitypaymentsduethereafter": 2969000,
    "lesseeoperatingleaseliabilitypaymentsdue": 8069000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 2524000,
    "accruedexternalresearchanddevelopmentexpensescurrent": 17746000,
    "employeerelatedliabilitiescurrent": 2630000,
    "accruedprofessionalfeescurrent": 803000,
    "otheraccruedliabilitiescurrent": 409000,
    "sharesissuedpricepershare": 12.57,
    "convertiblepreferredstocksharesissueduponconversion": 1000,
    "percentageofoutstandingcommonstockownedbyshareholders": 0.0999,
    "preferredstockliquidationpreference": 0.001,
    "preferredstockvotingrights": "no",
    "proceedsfromissuanceofcommonstockgross": 6000000,
    "proceedsfromissuanceinitialpublicoffering": 5800000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardrequisiteserviceperiod1": "P1Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P2Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 3635225,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 160200,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumnumberofsharestobeincremented": 607324,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofoutstandingstockmaximumtobeincremented": 0.04,
    "commonstockcapitalsharesreservedforfutureissuance": 489657,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 50000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.62,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 400000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 7700000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 2969428,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 291506,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.024,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.752,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 2969428,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1339002,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 8.13,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 8.25,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 6.46,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 8.21,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 8.13,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 7.56,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y11M8D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P7Y11M8D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P7Y29D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 6689000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 6689000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 3566000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 156800000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 157800000,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 73000000,
    "operatinglosscarryforwardsexpirationyear": 2039,
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 83800000,
    "deferredtaxassetsoperatinglosscarryforwardsforeign": 7700000,
    "deferredtaxassetstaxcreditcarryforwardsresearchanddevelopment": 1100000,
    "taxcreditcarryforwardexpirationperiod": 2028,
    "ownershipchangeincreaseinownershipbymaximumpercentage": 0.5,
    "ownershipchangeincreaseinownershippercentageterm": "P3Y",
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -62623000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": 1698000,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": -60925000,
    "effectiveincometaxratereconciliationtaxcreditsresearch": -0.03,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.067,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.008,
    "effectiveincometaxratereconciliationnondeductibleexpense": 0.011,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.304,
    "deferredtaxassetsoperatinglosscarryforwards": 44239000,
    "deferredtaxassetstaxcreditcarryforwards": 5220000,
    "deferredtaxassetsother": 2521000,
    "deferredtaxassetsgross": 51980000,
    "deferredtaxassetsvaluationallowance": 51980000,
    "valuationallowancedeferredtaxassetincreaseinamount": 17839000,
    "licenseagreementmilestonepaymentsuponachievementofspecifiedcommercialmilestone": 6600000,
    "contractterminationperiod": "P10Y",
    "contractterminationperiodifnomaterialdevelopmentorcommercializationoccurs": "P1Y",
    "periodofoptiongrantedonagreement": "P12M",
    "upfrontlicensefee": 2000000,
    "transactionpriceallocatedtoperformanceobligations": 1303000,
    "performanceobligationsexclusiveoptiontonegotiatelicense": 1000000,
    "performanceobligationsrelatedtoresearchanddevelopmentservicesmilestone": 2000000,
    "contractwithcustomerassetnetcurrent": 1700000,
    "revenueremainingperformanceobligation": 300000,
    "reductiontoresearchanddevelopmentexpense": 1700000,
    "performanceobligationstandalonesellingprice": 3614000,
    "revenueperformanceobligationsrecognitionmethoddescription": "Recognized over time as services are delivered through the expected completion date of Q2 2020",
    "taxincentiveresearchanddevelopmentactivities": 400000,
    "taxincentivereceivable": 800000
  }
]